Cardiovascular Actions of Selective Estrogen Receptor Modulators and Phytoestrogens

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Cardiovascular disease is the leading cause of death among men and women in Western societies. Over the past decade, interest in a better understanding of gender differences in cardiovascular disease has heightened. Concomitantly, the use of hormone therapy for cardiovascular risk reduction in postmenopausal women has come into question in light of recent landmark clinical studies casting doubt on the benefits of this therapy. As a consequence, alternatives to conventional hormone replacement, including selective estrogen receptor modulators and phytoestrogens, have attracted considerable attention. The authors provide an up-to-date review of the clinical actions of selective estrogen receptor modulators on cardiovascular disease. The actions of tamoxifen, raloxifene, droloxifene, and soy phytoestrogens are discussed in the context of cardiovascular disease epidemiology, coronary events, clinical markers of cardiovascular risk, and vascular function. In addition, the authors' current understanding of the mechanism of action of these agents is discussed and recommendations for clinical practice are reviewed.

Original languageEnglish (US)
JournalPreventive Cardiology
Volume7
Issue number2
DOIs
StateAccepted/In press - 2013

Fingerprint

Selective Estrogen Receptor Modulators
Phytoestrogens
Cardiovascular Diseases
Hormones
Tamoxifen
Risk Reduction Behavior
Blood Vessels
Cause of Death
Epidemiology
Biomarkers
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Cardiology and Cardiovascular Medicine

Cite this

@article{a43c136c07aa419fabd7e3e901695a2a,
title = "Cardiovascular Actions of Selective Estrogen Receptor Modulators and Phytoestrogens",
abstract = "Cardiovascular disease is the leading cause of death among men and women in Western societies. Over the past decade, interest in a better understanding of gender differences in cardiovascular disease has heightened. Concomitantly, the use of hormone therapy for cardiovascular risk reduction in postmenopausal women has come into question in light of recent landmark clinical studies casting doubt on the benefits of this therapy. As a consequence, alternatives to conventional hormone replacement, including selective estrogen receptor modulators and phytoestrogens, have attracted considerable attention. The authors provide an up-to-date review of the clinical actions of selective estrogen receptor modulators on cardiovascular disease. The actions of tamoxifen, raloxifene, droloxifene, and soy phytoestrogens are discussed in the context of cardiovascular disease epidemiology, coronary events, clinical markers of cardiovascular risk, and vascular function. In addition, the authors' current understanding of the mechanism of action of these agents is discussed and recommendations for clinical practice are reviewed.",
author = "Radhika Bukkapatnam and Kavita Kumar and Villablanca, {Amparo C}",
year = "2013",
doi = "10.1111/j.1520-037X.2006.2527.x",
language = "English (US)",
volume = "7",
journal = "Preventive Cardiology",
issn = "1520-037X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Cardiovascular Actions of Selective Estrogen Receptor Modulators and Phytoestrogens

AU - Bukkapatnam, Radhika

AU - Kumar, Kavita

AU - Villablanca, Amparo C

PY - 2013

Y1 - 2013

N2 - Cardiovascular disease is the leading cause of death among men and women in Western societies. Over the past decade, interest in a better understanding of gender differences in cardiovascular disease has heightened. Concomitantly, the use of hormone therapy for cardiovascular risk reduction in postmenopausal women has come into question in light of recent landmark clinical studies casting doubt on the benefits of this therapy. As a consequence, alternatives to conventional hormone replacement, including selective estrogen receptor modulators and phytoestrogens, have attracted considerable attention. The authors provide an up-to-date review of the clinical actions of selective estrogen receptor modulators on cardiovascular disease. The actions of tamoxifen, raloxifene, droloxifene, and soy phytoestrogens are discussed in the context of cardiovascular disease epidemiology, coronary events, clinical markers of cardiovascular risk, and vascular function. In addition, the authors' current understanding of the mechanism of action of these agents is discussed and recommendations for clinical practice are reviewed.

AB - Cardiovascular disease is the leading cause of death among men and women in Western societies. Over the past decade, interest in a better understanding of gender differences in cardiovascular disease has heightened. Concomitantly, the use of hormone therapy for cardiovascular risk reduction in postmenopausal women has come into question in light of recent landmark clinical studies casting doubt on the benefits of this therapy. As a consequence, alternatives to conventional hormone replacement, including selective estrogen receptor modulators and phytoestrogens, have attracted considerable attention. The authors provide an up-to-date review of the clinical actions of selective estrogen receptor modulators on cardiovascular disease. The actions of tamoxifen, raloxifene, droloxifene, and soy phytoestrogens are discussed in the context of cardiovascular disease epidemiology, coronary events, clinical markers of cardiovascular risk, and vascular function. In addition, the authors' current understanding of the mechanism of action of these agents is discussed and recommendations for clinical practice are reviewed.

UR - http://www.scopus.com/inward/record.url?scp=84876933578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876933578&partnerID=8YFLogxK

U2 - 10.1111/j.1520-037X.2006.2527.x

DO - 10.1111/j.1520-037X.2006.2527.x

M3 - Article

C2 - 15133375

AN - SCOPUS:84876933578

VL - 7

JO - Preventive Cardiology

JF - Preventive Cardiology

SN - 1520-037X

IS - 2

ER -